The rising incidences of bacterial, viral, fungal, or parasitic infections — where the cornea is directly invaded by microorganisms causing damage and inflammation are primarily fueling the growth of the keratitis market.

1. Keratitis Market
Research Report
2023-2033

2. ABOUT IMARC
2
International Market Analysis Research and Consulting Group is a
leading adviser on management strategy and market research
worldwide. We partner with clients in all regions and industry
verticals to identify their highest-value opportunities, address their
most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific,
economic and technological developments for business leaders in
pharmaceutical, industrial, and high technology organizations.
Market forecasts and industry analysis for biotechnology, advanced
materials, chemicals, food and beverage, travel and tourism,
nanotechnology and novel processing methods are at the top of
the company’s expertise.
IMARC’s tailored approach combines unfathomable insight into
the dynamics of companies and markets with close cooperation at
all levels of the client organization. This ensures that our clients
achieve unmatchable competitive advantage, build more proficient
organizations, and secure lasting results.

3. Report Description and Highlights
Keratitis Market 2023-2033
The newly published report by IMARC Group, titled ”Keratitis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity,
and Forecast 2023-2033″, presents a comprehensive analysis of the keratitis market. The report provides an overview of the market
trends, growth prospects, investment opportunities, and industry prospects, as well as an analysis of the disease overview, market
scenario, and growth trends. In addition, the report offers competitor analysis, regional analysis, and recent advancements in the seven
major markets (7MM). The report also highlights key segments and market drivers, as well as challenges faced by industry players.
Request a Sample Report: https://www.imarcgroup.com/keratitis-market/requestsample
3

4. Report Description and Highlights
What is Keratitis?
Keratitis refers to the inflammation or infection of the cornea, the clear, dome-shaped structure covering the eye’s front. This ailment
predominantly impairs the eye’s external structures, including the cornea and adjacent tissues. Some common symptoms include eye pain,
redness, blurred vision, light sensitivity (photophobia), profuse tearing or discharge, or the sensation of a foreign body in the eye. In more
severe instances, those afflicted might endure corneal ulcers or perforations, potentially resulting in vision impairment or blindness.
Keratitis diagnosis entails a thorough ocular examination, encompassing a comprehensive medical history review and symptom evaluation.
A healthcare provider may also conduct a slit-lamp examination to identify infiltrates such as inflammatory cells or infectious agents. If an
infection is deemed the potential cause of keratitis, a corneal culture may be undertaken to pinpoint the specific microorganism inciting
the ailment. Furthermore, anterior segment photography is employed to ascertain the disease’s extent and progression.
4

5. Report Description and Highlights
What are the key drivers and trends in the Keratitis market?
The rising incidences of bacterial, viral, fungal, or parasitic infections — where the cornea is directly invaded by microorganisms causing
damage and inflammation are primarily fueling the growth of the keratitis market. Besides this, the rising prevalence of various associated
risk factors, such as dry eyes, exposure to irritants, autoimmune disorders, ocular trauma, allergic reactions, and others, are aiding in
market expansion. Moreover, the increasing application of effective medications, including antibiotics, antifungals, and antivirals, to
manage infection and curb disease progression creates a favorable outlook for the market.
Additionally, the expanding use of artificial tears or lubricating eye drops, which help maintain a healthy tear film by hydrating the ocular
surface and reducing discomfort, is fueling the market growth. Furthermore, the surging popularity of phototherapeutic keratectomy,
which utilizes an excimer laser to accurately remove the cornea’s superficial layers, eliminating infected or scarred tissue and stimulating
the regeneration of healthy cells, is propelling the market forward.
5

6. Report Description and Highlights
What is included in the report segmentation?
The report covers the following aspects:
Report Period:
• Base Year: 2022
• Historical Period: 2017-2022
• Market Forecast: 2023-2033
Countries Included:
• United States
• Germany
• France
6

7. Report Description and Highlights
• United Kingdom
• Italy
• Spain
• Japan
Analysis Covered Across Each Country
• Historical, current, and future epidemiology scenario
• Historical, current, and future performance of the Keratitis market
• Historical, current, and future performance of various therapeutic categories in the market
• Sales of various drugs across the Keratitis market
• Reimbursement scenario in the market
• In-market and pipeline drugs
7

8. Report Description and Highlights
In-Market Drugs
• Drug Overview
• Mechanism of Action
• Regulatory Status
• Clinical Trial Results
• Drug Uptake and Market Performance
Late-Stage Pipeline Drugs
• Drug Overview
• Mechanism of Action
• Regulatory Status
• Clinical Trial Results
• Regulatory Status
View Report TOC, Figures and Tables: https://www.imarcgroup.com/keratitis-market
8

9. Key Questions Answered in the Report
1. How has the Keratitis market performed so far and how will it perform in the coming years?
2. What are the markets shares of various therapeutic segments in 2022 and how are they expected to perform till 2033?
3. What was the country-wise size of the Keratitis market across the seven major markets in 2022 and what will it look like in 2033?
4. What is the growth rate of the Keratitis market across the seven major markets and what will be the expected growth over the next ten
years?
5. What are the key unmet needs in the market?
9

10. Table of
Contents

11. Table of Contents
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
11

12. Table of Contents
4 Keratitis - Introduction
4.1 Overview
4.2 Regulatory Process
4.3 Epidemiology (2017-2022) and Forecast (2023-2033)
4.4 Market Overview (2017-2022) and Forecast (2023-2033)
4.5 Competitive Intelligence
5 Keratitis - Disease Overview
5.1 Introduction
5.2 Symptoms and Diagnosis
5.3 Pathophysiology
5.4 Causes and Risk Factors
5.5 Treatment
Click here to visit the complete table of content with list of figures and tables: https://www.imarcgroup.com/keratitis-market/toc
12

13. Partial List Of Our Clients
13

14. OUR CLIENTS
14

15. Disclaimer
15
© 2023 IMARC All Rights Reserved
This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis
Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or
in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including
photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of
International Market Analysis Research and Consulting (IMARC).
Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information
and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting
makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts
no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication.
IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and
Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.